Market Research Logo

Omega Pharma NV

Omega Pharma NV - Strategy and SWOT Report,

- is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.

Features:

  • Detailed information on Omega Pharma NV required for business and competitor intelligence needs
  • A study of the major internal and external factors affecting Omega Pharma NV in the form of a SWOT analysis
  • An in-depth view of the business model of Omega Pharma NV including a breakdown and examination of key business segments
  • Intelligence on Omega Pharma NV’s mergers and acquisitions (M&A), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
  • News about Omega Pharma NV, such as business expansion, restructuring, and contract wins
  • Large number of easy-to-grasp charts and graphs that present important data and key trends
Highlights:

Omega Pharma (Omega or 'the company'), a company owned by Omega Pharma Invest NV, is engaged in the development, marketing and sales of over-the-counter (OTC) pharmaceutical products. It also offers pain relief products, eye care products, sleep aid and anti-snoring products, slimming products, and home diagnostics. The company primarily operates in Europe. It is headquartered in Nazareth, Belgium, and employs about 2,500 people.Reasons to Purchase:

  • Gain understanding of Omega Pharma NV and the factors that influence its strategies
  • Track strategic initiatives of the company and latest corporate news and actions
  • Assess Omega Pharma NV as a prospective partner, vendor or supplier
  • Support sales activities by understanding your customers' businesses better
  • Stay up to date on Omega Pharma NV’s business structure, strategy and prospects

  • Company Snapshot
    Omega Pharma NV: Company Overview
    Omega Pharma NV: Overview and Key Facts
    Omega Pharma NV: Overview
    Omega Pharma NV: Key Facts
    Omega Pharma NV: Key Employees
    Omega Pharma NV: Key Employee Biographies
    Omega Pharma NV: Major Products and Services
    Omega Pharma NV: Company History
    Omega Pharma NV: Management Statement
    Omega Pharma NV: Locations and Subsidiaries
    Omega Pharma NV: Key Competitors
    Omega Pharma NV: Company Analysis
    Omega Pharma NV: Business Description
    Omega Pharma NV: SWOT Analysis
    Omega Pharma NV: SWOT Overview
    Omega Pharma NV: Strengths
    Omega Pharma NV: Weaknesses
    Omega Pharma NV: Opportunities
    Omega Pharma NV: Threats
    Omega Pharma NV: Corporate Financial Deals Activity
    Omega Pharma NV: Financial Deals Overview
    Omega Pharma NV: Targets and Partners
    Omega Pharma NV: Top Deals 2011 - 2015YTD*
    Omega Pharma NV: Advisors
    Omega Pharma NV: Top Legal Advisors
    Omega Pharma NV: Mergers and Acquisitions
    Omega Pharma NV: Partnership
    Omega Pharma NV: Private Equity and Ownership
    Appendix
    Contact Us
    Methodology
    Definitions
    About Market Line
    List of Tables
    Table 1: Omega Pharma NV: Key Facts
    Table 2: Omega Pharma NV: Key Employees
    Table 4: Omega Pharma NV: Key Competitors
    Table 5: Omega Pharma NV: Deal Activity by Deal Type - Volume (TTM*)
    Table 6: Omega Pharma NV: Deal Activity by Deal Type - Volume (2011 - YTD*2015)
    Table 7: Omega Pharma NV: M&A Average Deal Size - Value (US$m)
    Table 8: Omega Pharma NV: Targets and Partners
    Table 9: Omega Pharma NV: Top Deals 2011 - 2015YTD*
    Table 10: Omega Pharma NV: Legal Advisor Ranking by Value (US$m)
    Table 11: Omega Pharma NV: M&A Volume and Value Trend (2011 - YTD*2015)
    Table 12: Omega Pharma NV: M&A Activity by Geography (2011 - YTD*2015)
    Table 13: Omega Pharma NV: Partnership Volume and Value Trend (2011 - YTD*2015)
    Table 14: Omega Pharma NV: Partnership Trend by Deal Type (2011 - YTD*2015)
    Table 15: Omega Pharma NV: Private Equity and Ownership Volume and Value Trend (2011 - YTD*2015)
    Table 16: Omega Pharma NV: Private Equity and Ownership Volume by Deal Type (2011 - YTD*2015)
    List of Figures
    Figure 1: Omega Pharma NV: Deal Activity by Deal Type - Volume (TTM*)
    Figure 2: Omega Pharma NV: Deal Activity by Deal Type - Volume (2011 - YTD*2015)
    Figure 3: Omega Pharma NV: M&A Average Deal Size - Value (US$m)
    Figure 4: Omega Pharma NV: M&A Volume and Value Trend (2011 - YTD*2015)
    Figure 5: Omega Pharma NV: M&A Activity by Geography (2011 - YTD*2015)
    Figure 6: Omega Pharma NV: Partnership Volume and Value Trend (2011 - YTD*2015)
    Figure 7: Omega Pharma NV: Partnership Trend by Deal Type (2011 - YTD*2015)
    Figure 8: Omega Pharma NV: Private Equity and Ownership Volume and Value Trend (2011 - YTD*2015)
    Figure 9: Omega Pharma NV: Private Equity and Ownership Volume by Deal Type (2011 - YTD*2015)

    Download our eBook: How to Succeed Using Market Research

    Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

    Download eBook

    Share this report